About Synchron, Inc.

HR, IT, Marketing, Sales, Finance, Operations Jobs at Synchron

Synchron is a privately held medical device and neurotechnology company founded in 2012 by CEO Tom Oxley, headquartered at the Brooklyn Navy Yard, Brooklyn, New York, that develops a minimally invasive brain-computer interface (BCI) platform designed to help people with paralysis and severe physical disabilities control digital devices using neural signals alone. The company's flagship device, the Stentrode, is delivered through the jugular vein via a catheter-based endovascular procedure -- avoiding open brain surgery -- and sits within a blood vessel on the surface of the motor cortex, where it records neural activity and wirelessly transmits signals to an external device that translates them into digital commands. Synchron's technology is currently in late-stage clinical trials in the United States and Australia, with 10 implants placed in patients to date, and in November 2025 the company raised a $200 million Series D round -- bringing total funding to approximately $340 to $345 million from investors including Khosla Ventures, Gates Frontier, Bezos Expeditions, In-Q-Tel, and others. In early 2026, Synchron unveiled Chiral, a foundation model of human cognition trained on neural data, and announced a collaboration with Apple to develop BCI-enabled device control through Apple's Human Interface Device protocol. According to PitchBook, Synchron has approximately 127 employees, while LeadIQ's February 2026 data places the figure at approximately 132, and a January 2026 San Diego Business Journal profile cited over 70 -- figures should be treated as approximate given the company's active post-Series D hiring push. Its workforce spans Neuroscience and Biomedical Engineering -- which carry the highest volume of open roles -- alongside active teams in Software and AI Engineering, Clinical and Regulatory Affairs, Commercial Operations, and People & HR. This page lists the latest job openings at Synchron, offering professionals an opportunity to contribute to the frontier of implantable neurotechnology and brain-computer interface research at a company advancing clinical translation of BCI toward commercialization.